Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma
Stopped early · Not applicable
Conditions studied: Hodgkin's Lymphoma
In brief
The primary objective of the study is to determine the progression-free survival \[PFS\] at 36 months for patients with Hodgkin lymphoma who achieve a complete metabolic response as demonstrated by a negative fluorodeoxyglucose (FDG)-PET scan after one cycle of ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) who undergo abbreviated ABVD chemotherapy (3 cycles).
Key facts
- Study ID
- NCT00901303
- Run by
- Weill Medical College of Cornell University
- People needed
- 6
- Starts
- 2008-10-01
- Expected to finish
- 2011-05-23
- Last updated by the study team
- 2018-08-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically documented classical Hodgkin lymphoma according to the WHO Classification. Nodular lymphocyte predominant Hodgkin lymphoma is excluded
- No prior treatment (chemotherapy or radiation therapy) for Hodgkin lymphoma
- Measurable disease must be present either on physical examination or imaging studies. Any tumor mass measurable in two dimensions and > 2 cm is acceptable (or 1.5 cm if 0.5 cm slices are used as in spiral CT scans)
- Age ≥ 18
- Patients must have at least one hypermetabolic lesion identifiable on initial PET scan
- LVEF by ECHO or MUGA within institutional normal limits
- Initial laboratory data should be compatible with the administration of standard doses of ABVD chemotherapy
You may not qualify if…
- Patient has no known HIV infection
- Patient is non-pregnant and non-lactating. Due to the teratogenic potential of the agents used in this study, pregnant or nursing women may not be enrolled. Women and men of reproductive potential should agree to use an effective means of birth control
- No other history of lymphoproliferative disorder or granulomatous disease
Where it is running
- Weill Cornell Medical College — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.